1. Home
  2. KALA vs PRZO Comparison

KALA vs PRZO Comparison

Compare KALA & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.73

Market Cap

21.8M

Sector

Health Care

ML Signal

HOLD

Logo ParaZero Technologies Ltd.

PRZO

ParaZero Technologies Ltd.

HOLD

Current Price

$0.53

Market Cap

18.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALA
PRZO
Founded
2009
2014
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.8M
18.6M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
KALA
PRZO
Price
$0.73
$0.53
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
199.5K
430.7K
Earning Date
04-15-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
67.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.45
52 Week High
$20.58
$2.04

Technical Indicators

Market Signals
Indicator
KALA
PRZO
Relative Strength Index (RSI) 27.64 47.83
Support Level $0.50 $0.45
Resistance Level $1.81 $0.57
Average True Range (ATR) 0.21 0.04
MACD -0.11 0.01
Stochastic Oscillator 0.68 57.91

Price Performance

Historical Comparison
KALA
PRZO

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.

Share on Social Networks: